Georgia CEAL RESTORES Family Diabetes Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12+
SponsorMorehouse School of Medicine

About this trial

The goal of this clinical trial is to determine whether a family-based lifestyle intervention reduces the risk of type 2 diabetes (T2D) among parents and their children. The intervention will also evaluate how well the program supports healthy lifestyle behaviors and family engagement.

The primary outcome of this study is weight loss in parents.

Researchers will evaluate changes in participants' weight and lifestyle behaviors before the study compared to the end of the study (12 weeks post intervention) and 3 months after participation in the program.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Parent/guardian must identify as African American or Hispanic

Parent/guardian must be 18+ years residing in the same household as the child (i.e., biological or have legal guardianship for child)

Parent/guardian must have prediabetes (HbA1c level 5.7-6.4%) or be at risk of developing Type 2 diabetes using CDC's Pre-Diabetes Risk Test

Participant is willing to commit to participation in a 12-week, in-person, intervention study

Disqualifiers

Severe psychological disorders that may prevent/interfere with study -participation

Physical impairments that may prevent participation in moderate intensity physical activity

Previous diagnosis of diabetes

History of congestive heart failure

Trial design

Design model

Single group

Treatments tested in this trial

  • Family Diabetes Prevention

    Behavioral

    A weekly lifestyle modification program for families with at least one parent at high risk of developing diabetes.

Treatment groups

120 Participants
are divided into 1 treatment group
Group A: Single arm pre/post studyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Weight Reduction

Weight at 12 weeks (post intervention) and three month follow up

Time frame
From enrollment to the end of intervention at 6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Morehouse School of Medicine

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator